Psychosocial support for patients suffering from dementia and their care giving partners

Fostering autonomy through a combined training and support program in patient/care giver DYAds in mild to moderate DEMentia (DYADEM): a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN28074990

Enrollment

240

Registered

2012-03-01

Start date

2012-02-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders Dementia in Alzheimer's disease

Interventions

Intervention group: 9 sessions including socio and psychotherapeutic modules Control group: treatment as usual dementia consulting, information sheet Treatment group gets 9 weekly/ two-weekly session

duration: approximately 1 hour.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Community dwelling, diagnosed patients with mild to moderate dementia and their partner/ family caregiver 2. Are living together in one domestic home in Berlin, Germany 3. Are willing to participate together with their partner in the intervention

Exclusion criteria

Exclusion criteria: 1. Modified-Modified Schober Test (MMST) <15 2. Patient or partner/ family caregiver suffers from other specific psychiatric diseases (mental and behavioural disorders due to psychoactive substance use [ICD-10 F10-29])

Design outcomes

Primary

Measure	Time frame
Combined standardized score of Quality of Life: 1. WHO-QoL (caregiver) 2. QOL-AD (dementia patient)	—

Secondary

Measure	Time frame
1. Autonomy: 1.1. Activities of Daily Living (ADL)/ instrumental Activities of Daily Living (iADL) 1.2. Older Adults Overprotection Scale (OPSA) 1.3. Sense of Competence Questionnaire (SCQ) 2. Time to nursing home placement	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026